Mount Sinai Heart Hosts 21st Annual Live Symposium of Complex Coronary, Valvular, and Vascular Cases June 12-15
Live broadcasts of cardiac procedures will be transmitted from inside The Mount Sinai Hospital’s leading Cardiac Catheterization Laboratory to an audience of more than 1,000 medical experts
Mount Sinai Heart will host its innovative and prestigious 21st Annual 2018 Live Symposium of Complex Coronary, Valvular, and Vascular Cases from Tuesday, June 12, through Friday, June 15, at The Mount Sinai Hospital. More than 1,000 interventional cardiac specialists, interventional radiologists, vascular surgeons, cardiology fellows, nurses, technicians, and other allied health care professionals working in cardiac catheterization and vascular laboratories around the globe are expected to attend.
The special four-day event will feature broadcasts of complex cardiovascular interventional procedures performed in real time, as well as expert presentations and panel discussions on the latest advances and treatment approaches for complex coronary and cardiovascular disease. A robust agenda combines individual and collective presentations from expert clinicians and scholars in the field, including course directors Samin Sharma, MD, FSCAI, FACC; Annapoorna S. Kini, MD, MRCP, FACC; Roxana Mehran, MD, FACC, FSCAI; and Prakash Krishnan, MD, FACC.
"Our fields of interventional cardiology, structural heart disease, and endovascular intervention continue to evolve at a high speed each year with new and emerging clinical trial results, therapies, and technology," says Dr. Sharma, Director of Clinical and Interventional Cardiology at Mount Sinai Heart. "This is exactly why the world's leading interventionalists gather each year at Mount Sinai: to educate and update each other and our colleagues with the common mission of improving evidence-based medical care, procedural appropriateness, efficiency, and most of all, safety for our patients with coronary, valvular, and peripheral vascular diseases."
The primary focus will be on a multi-device approach to complex revascularization in patients with complex coronary, structural heart, and endovascular disease. The agenda will explore novel interventional devices and techniques such as transcatheter aortic valve replacement (TAVR), retrograde CTO recanalization, atherectomy for severely calcified lesions, and dedicated bifurcation stenting for patients with advanced coronary artery disease.
Friday, June 15, will be a nurse/technologist symposium devoted to various operational topics encountered in the catheterization laboratory. The directors of the symposium are Beth Oliver, DNP, RN, Senior Vice President of Cardiac Services for the Mount Sinai Health System; Jennifer Del Campo, MSN, FNP-C, Clinical Nurse Manager, Cardiac Catheterization Laboratory; and Haydee Garcia, MSN, ACNP-BS, Director of Nursing, The Mount Sinai Hospital.
Launched in 1998, Mount Sinai Heart's innovative Symposium continuously drives innovation in the field of interventional cardiovascular medicine and helps clinicians in the field achieve safer procedural outcomes and appropriately select the best procedure for each of their patients. For 20 consecutive years, the Cardiac Catheterization Laboratory of Mount Sinai Heart holds the "two-star" safety rating from the New York State's Department of Health for percutaneous coronary.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.